Michel Briejer

Michel, managing partner, joined Thuja Capital early 2008. Prior to that he held senior management positions in drug development both in the international pharmaceutical industry (e.g. Janssen Pharmaceutica (Belgium), Yamanouchi (currently Astellas Pharma)) as well as in the biotech industry (Crucell). Michel holds an MSc degree in Pharmacy (Utrecht University, cum laude) and a PhD in Pharmacology (Wageningen University), as well as a post-doctoral degree in Pharmaceutical Medicine (Dip.Phar.Med., European Center for Pharmaceutical Sciences, Basle).

Mobile: +31 6 2246 2927
Email | View my profile